Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nick Freemantle

Showing results (31-40 of 420) with videos related to

Pageof 42
Sort By:
Trials|August 12, 2006
Will availability of inhaled human insulin (Exubera) improve management of type 2 diabetes? The design of the Real World trialNick Freemantle, Thomas R Strack,
Lancet (London, England)|January 10, 2006
PROactive studyJohn S Yudkin, Nick Freemantle
ASAIO Journal (American Society for Artificial Internal Organs : 1992)|April 16, 2019
Interpreting Comparisons Between Clinical TrialsHoong Sern Lim, Nick Freemantle
Journal of Clinical Epidemiology|March 30, 2010
AHRQ series commentary 3: the United States addresses comparative effectiveness but not cost-effectiveness through the effective health-care programNick Freemantle, Michael F Drummond
Pharmacoeconomics|January 26, 2007
Is medication review by pharmacists of any use?Arnold G Zermansky, Nick Freemantle
Journal of the Royal Society of Medicine|February 12, 2009
Cost-effective undergraduate medical education?Melanie J Calvert, Nick Freemantle
The New England Journal of Medicine|June 9, 2021
Randomized Trials of Interventions for Hospitalized Patients with Cirrhosis. ReplyLouise China, Nick Freemantle, Alastair O'Brien
Journal of Clinical Epidemiology|April 2, 2011
Designing "Real-World" trials to meet the needs of health policy makers at marketing authorizationMelanie Calvert, John Wood, Nick Freemantle
BMJ (Clinical Research Ed.)|July 24, 2004
Challenges for the National Institute for Clinical ExcellenceAlan Maynard, Karen Bloor, Nick Freemantle
International Journal of Cardiology|August 6, 2005
Meta-analysis does not show that cardiac resynchronisation reduces all-cause mortalityJustin Ghosh, Nick Freemantle, John Cleland
Pageof 42

Showing results (31-40 of 420) with videos related to

Sort By:
Pageof 42
Trials|August 12, 2006
Will availability of inhaled human insulin (Exubera) improve management of type 2 diabetes? The design of the Real World trialNick Freemantle, Thomas R Strack,
Lancet (London, England)|January 10, 2006
PROactive studyJohn S Yudkin, Nick Freemantle
ASAIO Journal (American Society for Artificial Internal Organs : 1992)|April 16, 2019
Interpreting Comparisons Between Clinical TrialsHoong Sern Lim, Nick Freemantle
Journal of Clinical Epidemiology|March 30, 2010
AHRQ series commentary 3: the United States addresses comparative effectiveness but not cost-effectiveness through the effective health-care programNick Freemantle, Michael F Drummond
Pharmacoeconomics|January 26, 2007
Is medication review by pharmacists of any use?Arnold G Zermansky, Nick Freemantle
Journal of the Royal Society of Medicine|February 12, 2009
Cost-effective undergraduate medical education?Melanie J Calvert, Nick Freemantle
The New England Journal of Medicine|June 9, 2021
Randomized Trials of Interventions for Hospitalized Patients with Cirrhosis. ReplyLouise China, Nick Freemantle, Alastair O'Brien
Journal of Clinical Epidemiology|April 2, 2011
Designing "Real-World" trials to meet the needs of health policy makers at marketing authorizationMelanie Calvert, John Wood, Nick Freemantle
BMJ (Clinical Research Ed.)|July 24, 2004
Challenges for the National Institute for Clinical ExcellenceAlan Maynard, Karen Bloor, Nick Freemantle
International Journal of Cardiology|August 6, 2005
Meta-analysis does not show that cardiac resynchronisation reduces all-cause mortalityJustin Ghosh, Nick Freemantle, John Cleland
Pageof 42